 |
 |
|
|
|
|
Bq.
Lorena Salazar Aravena
Biochemist, University of Concepción
|
|
|
|
|
|
Publications |
|
|
|
|
|
• |
Salazar
L, Aravena O, Contreras-Levicoy J, Pesce B, Catalan
D, Zuniga R, Iruretagoyena M, Kalergis AM, Aguillón
JC.
Short-term lipopolysaccharide stimulation induces
differentiation of murine bone marrow-derived
dendritic cells into a tolerogenic phenotype.
|
|
|
• |
Pincheira
J, Romero P, Marcelain K, Salazar L, de la Torre
C.
G2 checkpoint-dependent DNA repair and its response
to catalase in Down syndrome and control lymphocyte
cultures. |
|
|
• |
Aguillón
JC, Cruzat A, Aravena O, Salazar L, Llanos C,
Cuchacovich M.
Could single-nucleotide polymorphisms (SNPs) affecting
the tumour necrosis factor promoter be considered
as part of rheumatoid arthritis evolution? |
|
|
• |
Llanos
C, Soto L, Sabugo F, Bastías MJ, Salazar
L, Aguillón JC, Cuchacovich M.
[The influence of -238 and -308 TNF alpha polymorphisms
on the pathogenesis and response to treatment
in rheumatoid arthritis][Article in Spanish] |
|
|
• |
Aguillón
JC, Cruzat A, Contreras-Levicoy J, Dotte A, Pesce
B, Aravena O, Salazar L, Catalán D, Abello
P, Aguirre A, Llanos C, Cuchacovich M.
[Emergent therapies for rheumatoid arthritis][Article
in Spanish] |
|
|
• |
Hagood
JS, Prabhakaran P, Kumbla P, Salazar L, MacEwen
MW, Barker TH, Ortiz LA, Schoeb T, Siegal GP,
Alexander CB, Pardo A, Selman M.
Loss of fibroblast Thy-1 expression correlates
with lung fibrogenesis. |
|
|
• |
Schiattino
I, Villegas R, Cruzat A, Cuenca J, Salazar L,
Aravena O, Pesce B, Catalán D, Llanos C,
Cuchacovich M, Aguillón JC.
Multiple imputation procedures allow the rescue
of missing data: an application to determine serum
tumor necrosis factor (TNF) concentration values
during the treatment of rheumatoid arthritis patients
with anti-TNF therapy. |
|
|
• |
Pérez
C, González FE, Pavez V, Araya AV, Aguirre
A, Cruzat A, Contreras-Levicoy J, Dotte A, Aravena
O, Salazar L, Catalán D, Cuenca J, Ferreira
A, Schiattino I, Aguillón JC.
The -308 polymorphism in the promoter region of
the tumor necrosis factor-alpha (TNF-alpha) gene
and ex vivo lipopolysaccharide-induced TNF-alpha
expression in patients with aggressive periodontitis
and/or type 1 diabetes mellitus. |
|
|
• |
Aguillón
JC, Contreras J, Dotte A, Cruzat A, Catalán
D, Salazar L, Molina MC, Guerrero J, López
M, Soto L, Salazar-Onfray F, Cuchacovich M.
[New immunological weapons for medicine in the
21st Century: biological therapy based on the
use of the latest generation monoclonal antibodies][Article
in Spanish] |
|
|
• |
|
|
|
• |
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
|